CA9 and nonpapillary renal cell carcinoma: As a proof-of-principle we first assessed DATE specificity in patient-derived models of ccRCC where CA9 is constitutively expressed, irrespective of oxygen tension, due to VHL loss (RCC243) and in the murine cortical adenocarcinoma renal cell carcinoma cell line (Renca) where we overexpressed CA9.